Delivery Order SPE2DB20D9127-SPE2DB24FPRB5

Award Date 7/18/24
Potential Completion Date 8/8/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $18,637.55 firm fixed-price delivery order is for the supply of PHOTREXA CROSS-LINKING KIT 6ML, with a period of performance through July 3, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery orders for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order valued at $7,455.02 for the supply of PHOTREXA CROSS-LINKING KIT 6ML, a specialized pharmaceutical product. This Delivery Order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,365.06 firm fixed-price delivery order is for the supply of PHOTREXA CROSS-LINKING KIT 6ML medical products and has an ultimate completion date of February 20, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,235.94 firm fixed-price delivery order is for the supply of Photrexa Cross-Linking Kits, a specialized pharmaceutical product. This award falls under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which enables the agency...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order valued at $9,855.93 for the supply of the "PHOTREXA CROSS-LINKING KIT 6ML" pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 7, 2023. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,319.42, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract covers the delivery of 4566735273 - PHOTREXA CROSS-LINKING KIT 6ML, a specialized pharmaceutical product, with a completion date of January 2, 2025. DMS Pharmaceutical Group holds a larger...
This federal contract award, valued at $19,711.86, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the PHOTREXA CROSS-LINKING KIT 6ML product, which is a specialized medical supply. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $9,855.93, is a firm fixed-price delivery order for the supply of a PHOTREXA CROSS-LINKING KIT 6ML product. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,855.93 firm fixed-price delivery order is for the supply of a pharmaceutical product, specifically the PHOTREXA CROSS-LINKING KIT 6ML. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,855.93 firm fixed-price delivery order is for the supply of a pharmaceutical product, specifically a "PHOTREXA CROSS-LINKING KIT 6ML." The award is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB24FPRB5
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is for the delivery of a specialized pharmaceutical product called PHOTREXA CROSS-LINKING KIT 6ML. The contract, awarded by the Defense Logistics Agency (DLA), is a firm fixed-price delivery order with a ceiling value of $23,235.94 and a performance period through August 8, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This contract award does not have a specific set-aside designation, enabling DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across various medical product categories. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides the DLA and Department of Defense healthcare sites with a diverse portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

Generated 2/27/25, 11:42 AM